Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content



2014-10-31@08:49:55 ET
AstraZeneca (AZN) Showing Support Near $71.67 (FBM)

2014-10-30@10:39:38 ET
Banks, Oil Companies Weigh on European ADRs (MID)

2014-10-30@08:52:48 ET
Sector Update: Health Stocks Mixed Pre-Bell (MID)

2014-10-30@08:34:19 ET
Sector Update: Health Care (MID)

2014-10-30@08:14:46 ET
AstraZeneca (AZN) Trading Near $70.71 Support Level (FBM)

2014-10-30@07:39:15 ET
AstraZeneca passes US FDA's approval for once-daily XIGDUO XR for treating adults with type 2 diabetes (MTO)

2014-10-30@07:02:49 ET
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes (BIZ)

2014-10-29@08:29:51 ET
AstraZeneca (AZN) Trading Near $70.57 Support Level (FBM)

2014-10-28@10:42:05 ET
European ADRs Gain on Earnings, Continental Banks, Telecoms Gain (MID)

2014-10-28@08:22:12 ET
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (NKTR, RPRX, MDCO, VRX, AZN) (F70)

2014-10-28@06:58:54 ET
Global Psychosis Clinical Trials Review, H2, 2014 (MTO)

2014-10-28@06:01:27 ET
Global Schizoaffective Disorder Clinical Trials Report H2, 2014 (MTO)

2014-10-27@15:44:37 ET
Potential AstraZeneca (AZN) Trade Has 4.99% Downside Protection (FBM)

2014-10-27@11:34:51 ET
European ADRs Lower on Oil Stock Losses (MID)

2014-10-24@18:16:49 ET
After Yesterday's Rally of 1.11% Shares Could Potentially Pullback (PSM)

2014-10-24@18:15:48 ET
SmarTrend Watching for Potential Pullback in Shares of AstraZeneca After 1.11% Gain (PSM)

2014-10-24@10:29:10 ET
Banks Lead Europe ADRs Higher Ahead of Stress Test Results (MID)

2014-10-24@09:36:54 ET
Pediatric Drugs and Vaccines - 2014 Global Strategic Business Report (MTO)

2014-10-23@17:08:00 ET
Global Pediatric Drugs and Vaccines Market (PRN)

2014-10-23@10:30:00 ET
Ardelyx's Tenapanor Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2014 (PRN)